FASN and metabolic dysfunction-associated steatotic liver disease: This suggests that reduced serum levels of FASN may be a concomitant clinical manifestation of NAFLD; therefore, it is speculated that the serum levels of FASN may be used as an auxiliary indicator for the clinical diagnosis of NAFLD.